Profile
Full Name
Gain Therapeutics, Inc.Ticker Symbol
GANXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
March 19, 2021Indexes
Not includedEmployees
23Key Details
Price
$1.74(+3.39%)
Market cap
$48.35M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.89(+47.95% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Gain Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 28, 25 Chardan Capital
BuyMar 17, 25 HC Wainwright & Co.
BuyMar 7, 25 Scotiabank
Sector OutperformDec 24, 24 Roth MKM
BuyDec 5, 24 Roth MKM
BuyNov 25, 24 HC Wainwright & Co.
BuyOct 9, 24 HC Wainwright & Co.
BuyOct 1, 24 HC Wainwright & Co.
BuySep 3, 24 HC Wainwright & Co.
BuyAug 9, 24 Chardan Capital
BuyInstitutional Ownership
- What is the ticker symbol for Gain Therapeutics?
- Does Gain Therapeutics pay dividends?
- What sector is Gain Therapeutics in?
- What industry is Gain Therapeutics in?
- What country is Gain Therapeutics based in?
- When did Gain Therapeutics go public?
- Is Gain Therapeutics in the S&P 500?
- Is Gain Therapeutics in the NASDAQ 100?
- Is Gain Therapeutics in the Dow Jones?
- When was Gain Therapeutics's last earnings report?
- When does Gain Therapeutics report earnings?
- Should I buy Gain Therapeutics stock now?
What is the ticker symbol for Gain Therapeutics?
The ticker symbol for Gain Therapeutics is NASDAQ:GANX
Does Gain Therapeutics pay dividends?
No, Gain Therapeutics does not pay dividends
What sector is Gain Therapeutics in?
Gain Therapeutics is in the Healthcare sector
What industry is Gain Therapeutics in?
Gain Therapeutics is in the Biotechnology industry
What country is Gain Therapeutics based in?
Gain Therapeutics is headquartered in United States
When did Gain Therapeutics go public?
Gain Therapeutics's initial public offering (IPO) was on March 19, 2021
Is Gain Therapeutics in the S&P 500?
No, Gain Therapeutics is not included in the S&P 500 index
Is Gain Therapeutics in the NASDAQ 100?
No, Gain Therapeutics is not included in the NASDAQ 100 index
Is Gain Therapeutics in the Dow Jones?
No, Gain Therapeutics is not included in the Dow Jones index
When was Gain Therapeutics's last earnings report?
Gain Therapeutics's most recent earnings report was on Mar 27, 2025
When does Gain Therapeutics report earnings?
The next expected earnings date for Gain Therapeutics is May 14, 2025
Should I buy Gain Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions